Picture of GoodRx Holdings logo

GDRX — GoodRx Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapSuper Stock

GoodRx Holdings Inc reports results for the quarter ended in January - Earnings Summary

* GoodRx Holdings Inc  GDRX.OQ  reported quarterly adjusted
earnings of 8 cents​​ per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of 7 cents.  The mean expectation of
eighteen analysts for the quarter was for earnings of 8 cents
per share. Wall Street expected results to range from 3 cents
to 10 cents per share.
    * Revenue rose 7.6% to $197.88 million from a year ago;
analysts
expected $196.08 million. 
    * GoodRx Holdings Inc's reported EPS for the quarter was
breakeven
results​.
    * The company reported a quarterly loss of $1.01 million.
    * GoodRx Holdings Inc shares had risen by 7.2% this
quarter and
gained 13.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 8.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 9
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the online
services
peer group is also "buy"

Wall Street's median 12-month price target for GoodRx Holdings
Inc is $9.00 
This summary was machine generated from LSEG data May 9 at 01:30
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.08           0.08           Met
 Dec. 31 2023      0.07           0.08           Beat
 Sep. 30 2023      0.06           0.06           Met
 Jun. 30 2023      0.06           0.07           Beat

Recent news on GoodRx Holdings

See all news